{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:38:57Z","timestamp":1793065137092,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100015515","name":"Kementerian Pendidikan Malaysia","doi-asserted-by":"publisher","award":["600-IRMI\/FRGS-RACER 5\/3 (015\/2019)"],"award-info":[{"award-number":["600-IRMI\/FRGS-RACER 5\/3 (015\/2019)"]}],"id":[{"id":"10.13039\/501100015515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"DOI":"10.1186\/s12884-025-07366-w","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:55:06Z","timestamp":1741866906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Maternal perfluoroalkyl and polyfluoroalkyl substances (PFAS) exposure and preeclampsia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Nurliana","family":"Abd Mutalib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Yusof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Shahril","family":"Ahmad Saman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti Hamimah","family":"Sheikh Abdul Kadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"issue":"7","key":"7366_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","volume":"124","author":"S Rana","year":"2019","unstructured":"Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019;124(7):1094\u2013112.","journal-title":"Circ Res"},{"issue":"8","key":"7366_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/OGX.0b013e3182331028","volume":"66","author":"D Raymond","year":"2011","unstructured":"Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv. 2011;66(8):497\u2013506.","journal-title":"Obstet Gynecol Surv"},{"issue":"12","key":"7366_CR3","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1039\/D0EM00291G","volume":"22","author":"J Gluge","year":"2020","unstructured":"Gluge J, Scheringer M, Cousins IT, DeWitt JC, Goldenman G, Herzke D, et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS). Environ Sci Process Impacts. 2020;22(12):2345\u201373.","journal-title":"Environ Sci Process Impacts"},{"issue":"Pt 1","key":"7366_CR4","doi-asserted-by":"publisher","first-page":"132468","DOI":"10.1016\/j.chemosphere.2021.132468","volume":"288","author":"B Liu","year":"2022","unstructured":"Liu B, Wei B, Mo M, Song Y, Tang C, Tang P, et al. Exposure to perfluoroalkyl substances in early pregnancy and the risk of hypertensive disorders of pregnancy: A nested case-control study in Guangxi, China. Chemosphere. 2022;288(Pt 1):132468.","journal-title":"Chemosphere"},{"issue":"7","key":"7366_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/aje\/kwt432","volume":"179","author":"AP Starling","year":"2014","unstructured":"Starling AP, Engel SM, Richardson DB, Baird DD, Haug LS, Stuebe AM, et al. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian mother and child cohort study. Am J Epidemiol. 2014;179(7):824\u201333.","journal-title":"Am J Epidemiol"},{"issue":"10","key":"7366_CR6","doi-asserted-by":"publisher","first-page":"107004","DOI":"10.1289\/EHP9091","volume":"129","author":"PA Bommarito","year":"2021","unstructured":"Bommarito PA, Ferguson KK, Meeker JD, McElrath TF, Cantonwine DE. Maternal levels of perfluoroalkyl substances (PFAS) during early pregnancy in relation to preeclampsia subtypes and biomarkers of preeclampsia risk. Environ Health Perspect. 2021;129(10):107004.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"7366_CR7","doi-asserted-by":"publisher","first-page":"9179","DOI":"10.1038\/s41598-019-45483-7","volume":"9","author":"S Wikstrom","year":"2019","unstructured":"Wikstrom S, Lindh CH, Shu H, Bornehag CG. Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women. Sci Rep. 2019;9(1):9179.","journal-title":"Sci Rep"},{"issue":"1","key":"7366_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12940-018-0445-3","volume":"18","author":"R Huang","year":"2019","unstructured":"Huang R, Chen Q, Zhang L, Luo K, Chen L, Zhao S, et al. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and the risk of hypertensive disorders of pregnancy. Environ Health. 2019;18(1):5.","journal-title":"Environ Health"},{"key":"7366_CR9","doi-asserted-by":"publisher","first-page":"105789","DOI":"10.1016\/j.envint.2020.105789","volume":"141","author":"MM Borghese","year":"2020","unstructured":"Borghese MM, Walker M, Helewa ME, Fraser WD, Arbuckle TE. Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the MIREC study. Environ Int. 2020;141:105789.","journal-title":"Environ Int"},{"issue":"12","key":"7366_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S2213-8587(21)00294-1","volume":"9","author":"T Burki","year":"2021","unstructured":"Burki T. PFAS: here today-here tomorrow. Lancet Diabetes Endocrinol. 2021;9(12):811\u20132.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"7366_CR11","doi-asserted-by":"publisher","first-page":"114002","DOI":"10.1289\/EHP7853","volume":"128","author":"W Nicole","year":"2020","unstructured":"Nicole W. Breaking it down: estimating Short-Chain PFAS Half-Lives in a human population. Environ Health Perspect. 2020;128(11):114002.","journal-title":"Environ Health Perspect"},{"issue":"4","key":"7366_CR12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ieam.258","volume":"7","author":"RC Buck","year":"2011","unstructured":"Buck RC, Franklin J, Berger U, Conder JM, Cousins IT, de Voogt P, et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr Environ Assess Manag. 2011;7(4):513\u201341.","journal-title":"Integr Environ Assess Manag"},{"issue":"24","key":"7366_CR13","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1080\/10643389.2019.1614848","volume":"49","author":"BC Crone","year":"2019","unstructured":"Crone BC, Speth TF, Wahman DG, Smith SJ, Abulikemu G, Kleiner EJ, et al. Occurrence of Per- and polyfluoroalkyl substances (PFAS) in source water and their treatment in drinking water. Crit Rev Environ Sci Technol. 2019;49(24):2359\u201396.","journal-title":"Crit Rev Environ Sci Technol"},{"issue":"6","key":"7366_CR14","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/s41370-021-00316-6","volume":"31","author":"RD Rogers","year":"2021","unstructured":"Rogers RD, Reh CM, Breysse P. Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations. J Expo Sci Environ Epidemiol. 2021;31(6):961\u201371.","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"8","key":"7366_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1021\/acs.estlett.0c00255","volume":"7","author":"CF Kwiatkowski","year":"2020","unstructured":"Kwiatkowski CF, Andrews DQ, Birnbaum LS, Bruton TA, DeWitt JC, Knappe DRU, et al. Scientific basis for managing PFAS as a chemical class. Environ Sci Technol Lett. 2020;7(8):532\u201343.","journal-title":"Environ Sci Technol Lett"},{"issue":"10","key":"7366_CR16","doi-asserted-by":"publisher","first-page":"100550","DOI":"10.1016\/j.jhepr.2022.100550","volume":"8","author":"JA Goodrich","year":"2022","unstructured":"Goodrich JA, Walker D, Lin X, Wang H, Lim T, McConnell R, Conti DV, Chatzi L, Setiawan VW. Exposure to perfluoroalkyl substances and risk of hepatocellular carcinoma in a multiethnic cohort. JHEP Rep. 2022;8(10):100550.","journal-title":"JHEP Rep"},{"issue":"8","key":"7366_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1021\/acs.chemrestox.2c00072","volume":"35","author":"JM Brown-Leung","year":"2022","unstructured":"Brown-Leung JM, Cannon JR. Neurotransmission targets of Per- and polyfluoroalkyl substance neurotoxicity: mechanisms and potential implications for adverse neurological outcomes. Chem Res Toxicol. 2022;35(8):1312\u201333. https:\/\/doi.org\/10.1021\/acs.chemrestox.2c00072. Epub 2022 Aug 3. PMID: 35921496; PMCID: PMC10446502.","journal-title":"Chem Res Toxicol"},{"key":"7366_CR18","doi-asserted-by":"publisher","first-page":"1103141","DOI":"10.3389\/fphys.2023.1103141","volume":"26","author":"D Liu","year":"2023","unstructured":"Liu D, Yan S, Wang P, Chen Q, Liu Y, Cui J, Liang Y, Ren S, Gao Y. Perfluorooctanoic acid (PFOA) exposure in relation to the kidneys: A review of current available literature. Front Physiol. 2023;26:14:1103141.","journal-title":"Front Physiol"},{"issue":"2","key":"7366_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s40572-024-00441-y","volume":"11","author":"AP Bline","year":"2024","unstructured":"Bline AP, DeWitt JC, Kwiatkowski CF, Pelch KE, Reade A, Varshavsky JR. Public health risks of PFAS-Related immunotoxicity are real. Curr Environ Health Rep. 2024;11(2):118\u201327. https:\/\/doi.org\/10.1007\/s40572-024-00441-y.","journal-title":"Curr Environ Health Rep"},{"key":"7366_CR20","doi-asserted-by":"publisher","first-page":"125159","DOI":"10.1016\/j.jhazmat.2021.125159","volume":"412","author":"B Xu","year":"2021","unstructured":"Xu B, Liu S, Zhou JL, Zheng C, Weifeng J, Chen B, et al. PFAS and their substitutes in groundwater: occurrence, transformation and remediation. J Hazard Mater. 2021;412:125159.","journal-title":"J Hazard Mater"},{"issue":"1","key":"7366_CR21","doi-asserted-by":"publisher","first-page":"e0245141","DOI":"10.1371\/journal.pone.0245141","volume":"16","author":"C Banwell","year":"2021","unstructured":"Banwell C, Housen T, Smurthwaite K, Trevenar S, Walker L, Todd K, et al. Health and social concerns about living in three communities affected by per- and polyfluoroalkyl substances (PFAS): A qualitative study in Australia. PLoS ONE. 2021;16(1):e0245141.","journal-title":"PLoS ONE"},{"key":"7366_CR22","doi-asserted-by":"crossref","unstructured":"Panieri E, Baralic K, Djukic-Cosic D, Buha Djordjevic A, Saso L. PFAS molecules: A major concern for the human health and the environment. Toxics. 2022;10(2).","DOI":"10.3390\/toxics10020044"},{"key":"7366_CR23","doi-asserted-by":"crossref","unstructured":"Zare Jeddi M, Dalla Zuanna T, Barbieri G, Fabricio ASC, Dapra F, Fletcher T et al. Associations of perfluoroalkyl substances with prevalence of metabolic syndrome in highly exposed young adult community Residents-A Cross-Sectional study in Veneto region, Italy. Int J Environ Res Public Health. 2021;18(3).","DOI":"10.3390\/ijerph18031194"},{"issue":"2","key":"7366_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1289\/ehp.0901165","volume":"118","author":"JW Nelson","year":"2010","unstructured":"Nelson JW, Hatch EE, Webster TF. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. Population. Environ Health Perspect. 2010;118(2):197\u2013202.","journal-title":"Environ Health Perspect"},{"key":"7366_CR25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.scitotenv.2017.07.124","volume":"608","author":"WW Bao","year":"2017","unstructured":"Bao WW, Qian ZM, Dee Geiger S, Liu E, Liu Y, Wan SQ, Lawrence WR, Yang BY, Hu LW, Zeng XW, Dong GH. Gender-specific association between serum isomers of perfluoroalkyl substances and blood pressure among Chinese: isomers of C8 health project in China. Sc Total Environ. 2017;608:1304.","journal-title":"Sc Total Environ"},{"key":"7366_CR26","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1289\/ehp.0901584","volume":"118","author":"D Melzer","year":"2010","unstructured":"Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National health and nutrition examination survey. Environ Health Perspect. 2010;118:686\u201392. https:\/\/doi.org\/10.1289\/ehp.0901584.","journal-title":"Environ Health Perspect"},{"key":"7366_CR27","doi-asserted-by":"publisher","first-page":"965384","DOI":"10.3389\/fendo.2022.965384","volume":"13","author":"K Roth","year":"2022","unstructured":"Roth K, Petriello MC. Exposure to per- and polyfluoroalkyl substances (PFAS) and type 2 diabetes risk. Front Endocrinol (Lausanne). 2022;13:965384. https:\/\/doi.org\/10.3389\/fendo.2022.965384. PMID: 35992116; PMCID: PMC9388934.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"7366_CR28","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1038\/s41598-021-82748-6","volume":"11","author":"S Wikstrom","year":"2021","unstructured":"Wikstrom S, Hussein G, Lingroth Karlsson A, Lindh CH, Bornehag CG. Exposure to perfluoroalkyl substances in early pregnancy and risk of sporadic first trimester miscarriage. Sci Rep. 2021;11(1):3568.","journal-title":"Sci Rep"},{"issue":"3","key":"7366_CR29","doi-asserted-by":"publisher","first-page":"100308","DOI":"10.1016\/j.ajogmf.2021.100308","volume":"3","author":"J Stone","year":"2021","unstructured":"Stone J, Sutrave P, Gascoigne E, Givens MB, Fry RC, Manuck TA. Exposure to toxic metals and per- and polyfluoroalkyl substances and the risk of preeclampsia and preterm birth in the united States: a review. Am J Obstet Gynecol MFM. 2021;3(3):100308.","journal-title":"Am J Obstet Gynecol MFM"},{"key":"7366_CR30","doi-asserted-by":"publisher","first-page":"e067946","DOI":"10.1136\/bmj-2021-067946","volume":"377","author":"W Ye","year":"2022","unstructured":"Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946.","journal-title":"BMJ"},{"key":"7366_CR31","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2014 [accessed 29 November 2022]. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"key":"7366_CR32","doi-asserted-by":"crossref","unstructured":"Abdullah Soheimi SS, Abdul Rahman A, Abd Latip N, Ibrahim E, Sheikh Abdul Kadir SH. Understanding the impact of perfluorinated compounds on cardiovascular diseases and their risk factors: A Meta-Analysis study. Int J Environ Res Public Health. 2021;18(16).","DOI":"10.3390\/ijerph18168345"},{"key":"7366_CR33","unstructured":"Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3: Cochrane; 2022 [accessed 29 November 2022]. Available from: www.training.cochrane.org\/handbook"},{"issue":"8","key":"7366_CR34","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1007\/s11606-018-4425-7","volume":"33","author":"L Lin","year":"2018","unstructured":"Lin L, Chu H, Murad MH, Hong C, Qu Z, Cole SR, et al. Empirical comparison of publication Bias tests in Meta-Analysis. J Gen Intern Med. 2018;33(8):1260\u20137.","journal-title":"J Gen Intern Med"},{"key":"7366_CR35","doi-asserted-by":"publisher","first-page":"146984","DOI":"10.1016\/j.scitotenv.2021.146984","volume":"783","author":"Z Deji","year":"2021","unstructured":"Deji Z, Liu P, Wang X, Zhang X, Luo Y, Huang Z. Association between maternal exposure to perfluoroalkyl and polyfluoroalkyl substances and risks of adverse pregnancy outcomes: A systematic review and meta-analysis. Sci Total Environ. 2021;783:146984.","journal-title":"Sci Total Environ"},{"key":"7366_CR36","doi-asserted-by":"crossref","unstructured":"Rylander L, Lindh CH, Hansson SR, Broberg K, Kallen K. Per- and polyfluoroalkyl substances in early pregnancy and risk for preeclampsia: A Case-Control study in Southern Sweden. Toxics. 2020;8(2).","DOI":"10.3390\/toxics8020043"},{"key":"7366_CR37","doi-asserted-by":"publisher","first-page":"106442","DOI":"10.1016\/j.envint.2021.106442","volume":"151","author":"A Birukov","year":"2021","unstructured":"Birukov A, Andersen LB, Andersen MS, Nielsen JH, Nielsen F, Kyhl HB, et al. Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the Odense child cohort. Environ Int. 2021;151:106442.","journal-title":"Environ Int"},{"issue":"13","key":"7366_CR38","doi-asserted-by":"publisher","first-page":"8158","DOI":"10.1021\/acs.est.9b07102","volume":"54","author":"J Bangma","year":"2020","unstructured":"Bangma J, Eaves LA, Oldenburg K, Reiner JL, Manuck T, Fry RC. Identifying risk factors for levels of Per- and polyfluoroalkyl substances (PFAS) in the placenta in a High-Risk pregnancy cohort in North Carolina. Environ Sci Technol. 2020;54(13):8158\u201366.","journal-title":"Environ Sci Technol"},{"key":"7366_CR39","doi-asserted-by":"publisher","first-page":"105656","DOI":"10.1016\/j.envint.2020.105656","volume":"138","author":"X Huo","year":"2020","unstructured":"Huo X, Huang R, Gan Y, Luo K, Aimuzi R, Nian M, et al. Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study. Environ Int. 2020;138:105656.","journal-title":"Environ Int"},{"issue":"1","key":"7366_CR40","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","volume":"21","author":"W Wang","year":"2021","unstructured":"Wang W, Xie X, Yuan T, Wang Y, Zhao F, Zhou Z, et al. Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and National levels: a population-based study. BMC Pregnancy Childbirth. 2021;21(1):364.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"7366_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"7366_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijheh.2011.08.011","volume":"215","author":"KB Gutzkow","year":"2012","unstructured":"Gutzkow KB, Haug LS, Thomsen C, Sabaredzovic A, Becher G, Brunborg G. Placental transfer of perfluorinated compounds is selective\u2013a Norwegian mother and child sub-cohort study. Int J Hyg Environ Health. 2012;215(2):216\u20139.","journal-title":"Int J Hyg Environ Health"},{"issue":"3 Pt 2","key":"7366_CR43","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1161\/01.HYP.38.3.718","volume":"38","author":"JP Granger","year":"2001","unstructured":"Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension. 2001;38(3 Pt 2):718\u201322.","journal-title":"Hypertension"},{"issue":"3","key":"7366_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s40572-020-00279-0","volume":"7","author":"JT Szilagyi","year":"2020","unstructured":"Szilagyi JT, Avula V, Fry RC. Perfluoroalkyl substances (PFAS) and their effects on the placenta, pregnancy, and child development: a potential mechanistic role for placental peroxisome Proliferator-Activated receptors (PPARs). Curr Environ Health Rep. 2020;7(3):222\u201330.","journal-title":"Curr Environ Health Rep"},{"issue":"6","key":"7366_CR45","doi-asserted-by":"publisher","first-page":"67001","DOI":"10.1289\/EHP11545","volume":"131","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wosu AC, Fleisch AF, Dunlop AL, Starling AP, Ferrara A, Dabelea D, Oken E, Buckley JP, Chatzi L, Karagas MR, Romano ME, Schantz S, O\u2019Connor TG, Woodruff TJ, Zhu Y, Hamra GB, Braun JM. The program collaborators for environmental influences on child health outcomes. Associations of gestational perfluoroalkyl substances exposure with early childhood BMI z-Scores and risk of overweight\/obesity: results from the ECHO cohorts. Environ Health Perspect. 2023;131(6):67001.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"7366_CR46","first-page":"e5","volume":"8","author":"T Hyotylainen","year":"2024","unstructured":"Hyotylainen T, McGlinchey A, Salihovic S, Schubert A, Douglas A, Hay DC, O\u2019Shaughnessy P, Iredale JP, Shaw S, Fowler PA, Oresic M. In utero exposures to perfluoroalkyl substances and the human fetal liver metabolome in Scotland: a cross-sectional study. Lancets. 2024;8(1):e5\u201317.","journal-title":"Lancets"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07366-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T11:55:10Z","timestamp":1741866910000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07366-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7366"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07366-w","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"8 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"279"}}